Search

Search Results
Results 6991 - 7000 of 7118 for parkinson
  • News - 15 Oct 2012
    During the Opening Session of the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, AAPS President David Y. Mitchell, Ph.D., presented the following...
  • Drug - 22 Feb 2024
    Consumer Medicine Information (CMI) about Ondansetron Tablets Viatris (Ondansetron hydrochloride dihydrate) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Gentamicin Sulfate (gentamicin) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Gentamicin Injection (gentamicin) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Amikacin Injection (amikacin) intended for persons living in Australia.
  • White Paper - 21 Jul 2023
    In this article, Sartorius demonstrates how they can characterize astrocyte models through live-cell analysis.
  • Drug - 28 Mar 2023
    Consumer Medicine Information (CMI) about Tobramycin Viatris (tobramycin) intended for persons living in Australia.
  • Drug - 6 Dec 2022
    Consumer Medicine Information (CMI) about Ondansetron Viatris (ondansetron hydrochloride dihydrate) intended for persons living in Australia.
  • Drug - 7 Oct 2022
    Consumer Medicine Information (CMI) about Tobramycin Injection (tobramycin sulfate) intended for persons living in Australia.
  • Drug - 7 Oct 2022
    Consumer Medicine Information (CMI) about DBL Tobramycin Injection (tobramycin) intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.